No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Technology Helps Diabetes Patients Lower Their A1C – By Sid Bala President of Calcium

Editor: What To Know

  • The main purpose of this quality improvement education initiative was to “…implement and evaluate the use of diabetes self-management education programs as a cost-effective measure in improving and sustaining glycemic control and overall individualized health outcomes of adult diabetes with Type 2 diabetes.
  • Lastly, the patient can then enter their own blood sugar measurement or meal calories in the app (or sync it with their devices), which can be reviewed by their care team to ensure the patient is following the plan.
  • This meant that their minimum A1C (a test to determine the average glucose in the blood in a 3–4-month period) measured over 8% (the recommended A1C is under 7%) and they struggled with maintaining the other aspects of their health care management plan.

By Sid Bala President of Calcium

Diabetes is a global problem. There are over half a billion Type 1 and Type 2 diabetics around the world with varying degrees of access to health care information, care, and funding. In the United States alone, almost 40 million diabetics face severe health risks due to accompanying chronic conditions like heart disease, stroke, and kidney failure.

Besides the prevalence of diabetes in our population, a key challenge is ensuring patients follow their health provider’s protocols for healthy living. Maintaining a healthy weight, keeping blood pressure and cholesterol under control, taking required medications and/or insulin, watching their diet, and participating in a regular exercise program all contribute to helping the patient manage their diabetes and lead the healthiest life possible. All of these activities are vital for diabetics, so how can a healthcare provider keep their patients on track?

Simple technology for a complex disease

Health care professionals are doing their best to meet this challenge and often new technologies are seen as an important way to start the patient on a path to healthier choices. Digital technologies like apps are prevalent throughout our society. There are apps for seemingly everything. From food prep to games and exercise monitors to smart home interfaces. Calcium, a digital health analytics company, has developed a platform which guides diabetics through easy-to-follow pathways that contribute to increased compliance with their care team’s plan, and most importantly, improved outcomes.

This technology was used as part of a quality improvement initiative conducted by an Ivy League university that monitored Type 2 diabetes patients through a program of diabetes education, supported by the Calcium app. The results of the initiative were extremely positive and speak to the importance of integrating technology in health care management programs.

Education in practice

The main purpose of this quality improvement education initiative was to “…implement and evaluate the use of diabetes self-management education programs as a cost-effective measure in improving and sustaining glycemic control and overall individualized health outcomes of adult diabetes with Type 2 diabetes.” The patients were all adults over the age of 18, had been diagnosed with type 2 diabetes, and were noncompliant with their diabetes management efforts. This meant that their minimum A1C (a test to determine the average glucose in the blood in a 3–4-month period) measured over 8% (the recommended A1C is under 7%) and they struggled with maintaining the other aspects of their health care management plan. The majority of the subjects were diagnosed over 10 years ago.

A key aspect of the technology is that it’s focused on education. It’s not punitive nor does it expose the user to any negative feedback. Its function is to monitor and remind, not scold. The participants were shown how to use the app and directed through a “participant pathway” for self-management education based on the curriculum created by the Association of Diabetes Care and Education Specialists. The content of the curriculum was divided into three basic tasks: Read. Watch. Do. More specifically, the participants were asked to:

  • Read something about diabetes education or look at pictures supplied by the initiative director
  • Watch a short video about a specific area of diabetes management
  • Do simple tasks within the app (e.g., enter food types, length of exercise, etc.)

All of these tasks reinforced the overall messaging of the education and helped the participant stay on track with their diabetes management efforts.

Working with a diabetes care team provides even more support. In what could be a typical use case, their primary care provider can help them understand the importance of monitoring their blood sugar and caloric intake. The patient can be assigned reading in the app about this (reinforcing the activity), then they can watch a video with someone demonstrating how to count calories. Lastly, the patient can then enter their own blood sugar measurement or meal calories in the app (or sync it with their devices), which can be reviewed by their care team to ensure the patient is following the plan. This reinforcing support can go a long way in improving a diabetic’s life and lessen the risks of out-of-control diabetes which could lead to dangerous chronic conditions.

There is also a behavioral component of the user experience on the app. The “gamification” aspect of the technology is a positive psychological boost to the user where they can set up leaderboards for “healthy” competition with family members or friends to keep engaged with their health journey. Also, syncing fitness trackers like Apple Watch or Fitbit which can help monitor vitals and other relevant health data is a fun way to stay on top of patients that are recovering from surgeries or just trying to get—and stay—healthier.

Positive signs through technology

A positive aspect of this educational effort—supported by this technology—is that the initiative saw some tangible successes among the participants using the app. As mentioned earlier, an A1C of under 7% is the target for most type 2 diabetics. The participants had A1C percentages of at least over 8. Among those who registered a “minimal use” or “significant use” of the app, there as an average 1.6% reduction in A1C levels over the course of the initiative. So, if a participant had an 8% A1C, they saw it reduced to under recommended levels simply by using the educational components, reminders, and engagement pathways of the app. This is key. Becoming engaged and taking ownership one’s own health is truly what makes this app effective. The care team noted, “Usually, when we start a new medication, it can improve the A1C level anywhere from 1.5% to 2%, depending [on] what medication we start them on. Using the app was comparable to starting a medication with the improvements that we saw.”

Engage and empower

Using technology to encourage patients to become more—and remain—engaged in their own health is a win-win for our healthcare system, its practitioners, and most importantly, the patients themselves. Simple reminders, basic task completions, along with integrated multimedia functions can empower patients to think healthier and be more engaged. Additionally, technology like this can be integrated with other devices like blood sugar monitors, blood pressure screeners, and fitness trackers to provide even more synchronicity for a whole health improvement program. The successful improvement of A1C levels in this quality initiative shows that strong patient engagement, through the use of technology, leads to healthy outcomes.

Editor’s Note: Sid Bala is President of Calcium and serves on the Board of Directors. Calcium believes a healthier world starts with healthier decisions. Their digital health analytics platform provides individuals with access to meaningful health data right at their fingertips, by employing easy, fun-to-use tools and personalized guidance that make healthier decisions easier. As a seasoned leader with more than 30 years of technology experience, Sid previously served as the Founder and CEO of alligatortek. Under Sid’s leadership, the company was recognized as a best-in-class partner, employer and innovator.

He also serves as Board Chair for Bookwallah, on the Quality and Cost Effectiveness Committee of the Board of Silver Cross Hospital and on the Membership Commission at The Chicago Club. He previously served on the Business Community & Culture Committee for P33 Chicago and as a Board Member of the Chicago Chapter of Entrepreneurs Organization (EO).

A Chicago native, Sid attended the University of Chicago for his bachelor’s degree in applied mathematics and went on to the State University of New York, Stony Brook for a graduate degree in computer science. He holds a master’s degree from MIT’s Entrepreneurial Masters Program.

He has been an ECC member since 2005 and has served as Chair of the Reception Committee and as Chair of the Membership Committee. He is past Secretary to the Board of Directors.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy